Carson Linda F相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study

在已进行最佳肿瘤细胞减灭术的IIIC期上皮性卵巢癌中，腹膜后探查的作用是什么？一项NRG肿瘤学/妇科肿瘤学组辅助数据研究

影响因子:5.1

doi:10.1002/cncr.30414

Rungruang, Bunja J; Miller, Austin; Krivak, Thomas C; Horowitz, Neil S; Rodriguez, Noah; Hamilton, Chad A; Backes, Floor J; Carson, Linda F; Friedlander, Michael; Mutch, David G; Goodheart, Michael J; Tewari, Krishnansu S; Wenham, Robert M; Bookman, Michael A; Maxwell, G Larry; Richard, Scott D

细胞生物学

发表日期：2017

文献求助收藏

Enhanced Recovery Program and Length of Stay After Laparotomy on a Gynecologic Oncology Service: A Randomized Controlled Trial

妇科肿瘤科腹腔镜手术后加速康复方案与住院时间的关系：一项随机对照试验

期刊:Obstetrics and Gynecology

影响因子:4.7

doi:10.1097/AOG.0000000000001838

Dickson, Elizabeth L; Stockwell, Erica; Geller, Melissa A; Vogel, Rachel Isaksson; Mullany, Sally A; Ghebre, Rahel; Witherhoff, Boris J N; Downs, Levi S Jr; Carson, Linda F; Teoh, Deanna; Glasgow, Michelle; Gerber, Matt; Rivard, Colleen; Erickson, Britt K; Hutchins, Jacob; Argenta, Peter A

发表日期：2017

文献求助收藏

A prospective, randomized trial of integrative medicine for women with ovarian cancer

一项针对卵巢癌女性的综合医学前瞻性随机试验

期刊:Gynecologic Oncology

影响因子:4.1

doi:10.1016/j.ygyno.2011.07.099

Judson, Patricia L; Dickson, Elizabeth L; Argenta, Peter A; Xiong, Yin; Geller, Melissa A; Carson, Linda F; Ghebre, Rahel; Jonson, Amy L; Downs, Levi S Jr

发表日期：2011

文献求助收藏

A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer

一项针对III期、IV期和复发性子宫内膜癌的II期临床试验，研究了卡铂和多西他赛联合放疗（采用“三明治”疗法）的疗效。

期刊:Gynecologic Oncology

影响因子:4.1

doi:10.1016/j.ygyno.2010.12.338

Geller, Melissa A; Ivy, Joseph J; Ghebre, Rahel; Downs, Levi S Jr; Judson, Patricia L; Carson, Linda F; Jonson, Amy L; Dusenbery, Kathryn; Vogel, Rachel Isaksson; Boente, Matthew P; Argenta, Peter A

子宫内膜癌

发表日期：2011

文献求助收藏

Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers.

在接受过大量预处理的复发性乳腺癌、卵巢癌和宫颈癌中，采用皮下注射 Toll 样受体-7 激动剂进行长期给药

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-010-0914-1

Geller Melissa A, Cooley Sarah, Argenta Peter A, Downs Levi S, Carson Linda F, Judson Patricia L, Ghebre Rahel, Weigel Brenda, Panoskaltsis-Mortari Angela, Curtsinger Julie, Miller Jeffrey S

Toll-Like Receptor

发表日期：2010

文献求助收藏